Ignite Creation Date:
2024-05-05 @ 9:36 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004941
Status:
COMPLETED
Last Update Posted:
2015-03-25
First Post:
2000-02-24
Brief Title:
Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody cA2 for Patients With Enterocutaneous Fistulae as a Complication of Crohns Disease
Sponsor:
FDA Office of Orphan Products Development
Organization:
FDA Office of Orphan Products Development
Key Dates - Follows AllAPIJSON File Order
Start Date:
1996-07
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
1996-07
Completion Date Type:
None
First Submit Date:
2000-02-24
First Submit QC Date:
February 24 2000
Study First Post Date:
2000-02-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-03-24
Last Update Post Date:
2015-03-25
Last Update Post Date Type:
ESTIMATED